J1-4170 — Annual report 2011
1.
Inhibitory peptdes of MyD88 signaling pathway

The field of invention is a new inhibitory peptide containing a segment which inhibits the activation of MyD88. The invention comprises the inhibitory peptide and its application for treatment of disease states connected with excessive activation of the innate immune response.

F.09 Development of a new technological process or technology

COBISS.SI-ID: 4380954
2.
Molecular mechanism of activation and inhibition inTLR4 and MyD88 mediated signaling

Lecture at the University of Osaka, in the most succesfull research group in immunology in the world.

B.04 Guest lecture

COBISS.SI-ID: 4905498
3.
The role of adapter protein domains in activation MYD88 innate immunity

The doctoral work of Dr.. Monika Avbelj explored the role of intermediate and N-terminal domain adapter MyD88.

F.02 Acquisition of new scientific knowledge

COBISS.SI-ID: 259787520